Caris Life Sciences reported cash from operations of $28.48M and free cash flow of $6.40M for the quarter ended Jun 2026, up 290.7% year over year. This cash flow statement covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | -66.19M | -67.73M | -36.95M | -102.58M | -71.79M | 24.32M | 81.96M | -0.51M | -0.64M |
| Share-based CompensationStock Comp. | 4.72M | 4.98M | 14.69M | 28.29M | 13.65M | 13.37M | 15.87M | 22.22M | |
| Cash from OperationsCash from Ops. | -69.43M | -38.92M | -31.34M | 7.29M | 62.42M | 44.78M | 32.88M | 28.48M | |
| Depreciation, Depletion & Amortization | |||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 1.73M | 1.83M | 1.91M | 1.95M | 7.75M | 2.46M | 0.60M | 2.62M | 0.30M |
| Depreciation & Amortization (CF)Dep. & Amort. | 11.60M | 10.50M | 9.07M | 7.04M | 6.40M | 4.90M | 4.29M | 5.10M | 6.50M |
| Change in Working Capital | |||||||||
| Change in ReceivablesChange Receivables | -1.90M | 18.81M | -7.91M | -29.13M | -24.19M | 91.02M | -21.62M | 26.37M | |
| Change in InventoryChange Inventory | 3.29M | -1.25M | -2.06M | 4.68M | 8.52M | 9.61M | 13.33M | 48.31M | |
| Change in Account PayablesChange Payables | 2.43M | -5.28M | -1.74M | -0.19M | 0.73M | 12.23M | 16.37M | 23.26M | |
| Change in Accured ExpensesChange Accured Exp. | -16.45M | 14.82M | 2.58M | -21.26M | 0.89M | 29.27M | -14.98M | 25.08M | |
| Investing Activities | |||||||||
| Capital ExpendituresCapex | 1.83M | 2.29M | 2.69M | 1.39M | 7.09M | 5.09M | 10.34M | 22.07M | |
| Cash from Investing ActivitiesCash from Investing | -1.83M | -2.29M | -2.69M | -1.39M | -7.09M | -5.09M | -10.34M | -122.19M | |
| Financing Activities | |||||||||
| Other financing activitiesOther financing | 0.66M | 0.27M | 1.43M | 527.02M | 0.92M | 2.02M | |||
| Cash from Financing ActivitiesCash from Financing | 0.09M | 0.23M | 1.28M | 681.40M | -21.10M | 3.40M | 0.82M | -36.90M | |
| Additional items | |||||||||
| Exchange Rate EffectFX Effect | -0.02M | -0.00M | 0.00M | 0.09M | 0.06M | -0.03M | -0.01M | -0.03M | |
| Change in Cash | -71.18M | -40.99M | -32.74M | 687.40M | 34.30M | 43.06M | 23.35M | -130.65M | |
| Free Cash FlowFCF | -71.25M | -41.21M | -34.03M | 5.90M | 55.33M | 39.69M | 22.53M | 6.40M | |
| Net Cash FlowNCF | -71.17M | -40.98M | -32.74M | 687.30M | 34.23M | 43.09M | 23.36M | -130.62M |